West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 95,700 | 64,700 | 27,100 | 112,300 | 88,700 |
| Depreciation Amortization | 68,000 | 44,900 | 21,800 | 85,200 | 63,100 |
| Income taxes - deferred | N/A | N/A | N/A | 1,700 | N/A |
| Accounts receivable | N/A | N/A | N/A | -9,100 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 4,600 | N/A |
| Other Working Capital | -36,200 | -43,600 | -43,200 | -3,700 | -11,900 |
| Other Operating Activity | 9,400 | 7,000 | 3,100 | 29,500 | 11,800 |
| Operating Cash Flow | $136,900 | $73,000 | $8,800 | $220,500 | $151,700 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,500 | -1,000 | -4,200 | 4,900 | 5,000 |
| PPE Investments | -84,800 | -56,200 | -31,700 | -151,900 | -113,100 |
| Net Acquisitions | N/A | N/A | N/A | -3,900 | N/A |
| Other Investing Activity | -400 | 200 | 300 | 1,000 | -2,900 |
| Investing Cash Flow | $-77,700 | $-57,000 | $-35,600 | $-149,900 | $-111,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 43,200 | 43,300 |
| Debt Repayment | 220,700 | 181,800 | 124,700 | 262,200 | 219,900 |
| Common Stock Issued | 12,700 | 6,700 | 3,200 | 24,200 | 17,000 |
| Common Stock Repurchased | -4,100 | -4,100 | -4,100 | -5,200 | -5,200 |
| Dividend Paid | -21,200 | -14,100 | -7,100 | -26,700 | -19,700 |
| Other Financing Activity | -237,100 | -189,300 | -90,500 | -302,800 | -236,900 |
| Financing Cash Flow | $-29,000 | $-19,000 | $26,200 | $-5,100 | $18,400 |
| Exchange Rate Effect | -13,400 | -300 | 600 | 2,600 | 700 |
| Beginning Cash Position | 230,000 | 230,000 | 230,000 | 161,900 | 161,900 |
| End Cash Position | 246,800 | 226,700 | 230,000 | 230,000 | 221,700 |
| Net Cash Flow | $16,800 | $-3,300 | $0 | $68,100 | $59,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 136,900 | 73,000 | 8,800 | 220,500 | 151,700 |
| Capital Expenditure | -84,800 | -56,200 | -31,700 | -151,900 | -113,100 |
| Free Cash Flow | 52,100 | 16,800 | -22,900 | 68,600 | 38,600 |